Mark A. Geyer
1972–2021 年に発表
- 別表記
- Mark A Geyer
- 187
- 論文数
- 37,305
- 被引用数
- 114
- h 指数
- 187
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Neuroscience42.7%
- Medicine19.9%
- Psychology16.7%
- Biochemistry, Genetics and Molecular Biology14.5%
- Computer Science1.2%
- Pharmacology, Toxicology and Pharmaceutics1%
- その他4%
トピック
- Neurotransmitter Receptor Influence on Behavior8.9%
- Neuroscience and Neuropharmacology Research6.1%
- Stress Responses and Cortisol4.2%
- Tryptophan and brain disorders4%
- Receptor Mechanisms and Signaling3.9%
- Neuroendocrine regulation and behavior3.8%
- その他69.1%
共著者
- David Braff37
- Neal R. Swerdlow36
- Jared W. Young22
- Martin P. Paulus17
- Arpi Minassian13
- Susan B. Powell13
- William Perry13
- Franz X. Vollenweider12
- Victoria B. Risbrough11
- Adam L. Halberstadt10
- Stephanie C. Dulawa9
- Gregory A. Light8
- Robert S. Mansbach7
- Virginia L. Masten7
- Alexander B. Niculescu6
- Brook L. Henry6
- Kristin S. Cadenhead6
- Richard F. Sharp6
- Arnold J. Mandell5
- H Le-Niculescu5
- Nicholas J. Schork5
- Adam X. Maihofer4
- David L. Braff4
- Dewleen G. Baker4
全論文
- Habituation revisited: An updated and revised description of the behavioral characteristics of habituation
著者: Catharine H. Rankin, Thomas W. Abrams, Robert J. Barry, Seema Bhatnagar, David F. Clayton, John Colombo, Gianluca Coppola, Mark A. Geyer, David L. Glanzman, Stephen Marsland, Frances K. McSweeney, Donald A. Wilson, Chun-Fang Wu, Richard F. Thompson - Neurobiology of Learning and Memory 2008 被引用: 1,669
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
著者: Mark J. Millan, Yves Agid, Martin Brüne, Edward T. Bullmore, Cameron S. Carter, Nicola S. Clayton, Richard C. Connor, Sabrina Davis, J.F.W. Deakin, Robert J. DeRubeis, Bruno Dubois, Mark A. Geyer, Guy M. Goodwin, Philip Gorwood, Thérèse M. Jay, Marian Joëls, Isabelle M. Mansuy, Andreas Meyer‐Lindenberg, Declan Murphy, Edmund T. Rolls, B. Saletu, Michael Spedding, John A. Sweeney, Miles A. Whittington, Larry J. Young - Nature Reviews Drug Discovery 2012 被引用: 1,297
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
著者: Adam L. Halberstadt, Mark A. Geyer - Neuropharmacology 2011 被引用: 418
- Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
著者: Adam L. Halberstadt, Liselore Koedood, Susan B. Powell, Mark A. Geyer - Journal of Psychopharmacology 2010 被引用: 212
- Characterization of the head-twitch response induced by hallucinogens in mice
著者: Adam L. Halberstadt, Mark A. Geyer - Psychopharmacology 2013 被引用: 216
- Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
著者: Boris B. Quednow, Michael Kometer, Mark A. Geyer, Franz X. Vollenweider - Neuropsychopharmacology 2011 被引用: 241
- A systems model of altered consciousness: integrating natural and drug-induced psychoses
著者: Franz X. Vollenweider, Mark A. Geyer - Brain Research Bulletin 2001 被引用: 348
- Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction
著者: Mohammed Ayalew, H Le-Niculescu, Daniel F. Levey, Neha Jain, B Changala, Sagar D. Patel, Evan A. Winiger, Alan Breier, Anantha Shekhar, Richard Amdur, Daphne Koller, John I. Nürnberger, Aiden Corvin, Mark A. Geyer, Ming T. Tsuang, Daniel R. Salomon, Nicholas J. Schork, Ayman H. Fanous, Michael O‘Donovan, Alexander B. Niculescu - Molecular Psychiatry 2012 被引用: 406
- Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2 R,3 R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist
著者: Kimberly E. Vanover, David M. Weiner, Malath Makhay, Isaac Veinbergs, Luis R. Gardell, Jelveh Lameh, Andria L. Del Tredici, Fabrice Piu, Hans H. Schiffer, Thomas Ott, Ethan S. Burstein, Allan K Uldam, Mikkel B. Thygesen, Nathalie Schlienger, Carl Magnus Andersson, Thomas Son, Scott C. Harvey, Susan B. Powell, Mark A. Geyer, Bo-Ragner Tolf, Mark R. Brann, Robert E. Davis - Journal of Pharmacology and Experimental Therapeutics 2006 被引用: 203
- Effect of Hallucinogens on Unconditioned Behavior
著者: Adam L. Halberstadt, Mark A. Geyer - Current topics in behavioral neurosciences 2016 被引用: 102
- Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
著者: David Braff, Mark A. Geyer, Neal R. Swerdlow - Psychopharmacology 2001 被引用: 1,724
- Serotonin research: contributions to understanding psychoses
著者: Mark A. Geyer, Franz X. Vollenweider - Trends in Pharmacological Sciences 2008 被引用: 435
- The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval
著者: Franz X. Vollenweider, Philipp Csomor, Bernhard Knappe, Mark A. Geyer, Boris B. Quednow - Neuropsychopharmacology 2007 被引用: 194
- 5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice
著者: Adam L. Halberstadt, Iris van der Heijden, Michael A. Ruderman, Victoria B. Risbrough, Jay A. Gingrich, Mark A. Geyer, Susan B. Powell - Neuropsychopharmacology 2009 被引用: 174
- Genetic loci associated with heart rate variability and their effects on cardiac disease risk
著者: Ilja M. Nolte, M. Loretto Muñoz, Vinicius Tragante, Azmeraw T. Amare, Rick Jansen, Ahmad Vaez, Benedikt von der Heyde, Christy L. Avery, Joshua C. Bis, Bram Dierckx, Jenny van Dongen, Stephanie M. Gogarten, Philippe Goyette, Jussi Hernesniemi, Ville Huikari, Shih-Jen Hwang, Deepali Jaju, Kathleen F. Kerr, Alexander Kluttig, Bouwe P. Krijthe, Jitender Kumar, Sander W. van der Laan, Leo‐Pekka Lyytikäinen, Adam X. Maihofer, Arpi Minassian, Peter J. van der Most, Martina Müller‐Nurasyid, Michel G. Nivard, Erika Salvi, James D. Stewart, Julian F. Thayer, Niek Verweij, Andrew Wong, Delilah Zabaneh, Mohammad Hadi Zafarmand, Abdel Abdellaoui, Sulayma Albarwani, Christine M. Albert, Álvaro Alonso, Foram N. Ashar, Juha Auvinen, Tomas Axelsson, Dewleen G. Baker, Paul I. W. de Bakker, Matteo Barcella, Riad Bayoumi, Rob J. Bieringa, Dorret I. Boomsma, Gabrielle Boucher, Annie Britton, Ingrid E. Christophersen, Andrea Dietrich, G. Ehret, Patrick T. Ellinor, Markku Eskola, Janine F. Felix, John S. Floras, Oscar H. Franco, Peter Friberg, Maaike G. J. Gademan, Mark A. Geyer, Vilmantas Giedraitis, Catharina A. Hartman, Daiane Hemerich, Albert Hofman, Jouke‐Jan Hottenga, Heikki V. Huikuri, Nina Hutri‐Kähönen, Xavier Jouven, Juhani Junttila, Markus Juonala, Antti M. Kiviniemi, Jan A. Kors, Meena Kumari, Tatiana Kuznetsova, Cathy C. Laurie, Joop D. Lefrandt, Yong Li, Yun Li, Duanping Liao, Marian C. Limacher, Henry J. Lin, Cecilia M. Lindgren, Steven A. Lubitz, Anubha Mahajan, Barbara McKnight, Henriette E. Meyer zu Schwabedissen, Yuri Milaneschi, Nina Mononen, Andrew P. Morris, Mike A. Nalls, Gerjan Navis, Melanie Neijts, Kjell Nikus, Kari E. North, Daniel T. O’Connor, Johan Ormel, Siegfried Perz, Annette Peters, Bruce M. Psaty ほか 64 名 - Nature Communications 2017 被引用: 164
- The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats
著者: Kirsten Krebs-Thomson, Erbert M. Ruiz, Virginia L. Masten, Mahálah R. Buell, Mark A. Geyer - Psychopharmacology 2006 被引用: 96
- Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges
著者: Neal R. Swerdlow, Mark A. Geyer, David Braff - Psychopharmacology 2001 被引用: 1,065
- Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
著者: Athina Markou, Cristiano Chiamulera, Mark A. Geyer, Mark D. Tricklebank, Thomas Steckler - Neuropsychopharmacology 2008 被引用: 324
- Analysis of Genetically Regulated Gene Expression Identifies a Prefrontal PTSD Gene, SNRNP35, Specific to Military Cohorts
著者: Laura M. Huckins, Chris Chatzinakos, Michael S. Breen, Jakob Hartmann, Torsten Klengel, Ana Carolina da Silva Almeida, Amanda Dobbyn, Kiran Girdhar, Gabriel E. Hoffman, Claudia Klengel, Mark W. Logue, Adriana Lori, Adam X. Maihofer, Filomene G. Morrison, Hoang T. Nguyen, Yongjin Park, Douglas M. Ruderfer, Laura Sloofman, Sanne J.H. van Rooij, Dewleen G. Baker, Chia‐Yen Chen, Nancy J. Cox, Laramie E. Duncan, Mark A. Geyer, Stephen J. Glatt, Hae Kyung Im, Victoria B. Risbrough, Jordan W. Smoller, Dan J. Stein, Rachel Yehuda, Israel Liberzon, Karestan C. Koenen, Tanja Jovanović, Manolis Kellis, Mark W. Miller, Silviu‐Alin Bacanu, Caroline M. Nievergelt, Joseph D. Buxbaum, Pamela Sklar, Kerry J. Ressler, Eli A. Stahl, Nikolaos P. Daskalakis - Cell Reports 2020 被引用: 68
- Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
著者: David Braff, C. Stone, Enoch Callaway, Mark A. Geyer, Ira Glick, Likh Bali - Psychophysiology 1978 被引用: 1,178
- Prepulse inhibition and genetic mouse models of schizophrenia
著者: Susan B. Powell, Xianjin Zhou, Mark A. Geyer - Behavioural Brain Research 2009 被引用: 218
- Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next
著者: Neal R. Swerdlow, David Braff, Mark A. Geyer - Journal of Psychopharmacology 2016 被引用: 189
- Tactile prepuff inhibition of startle in children with Tourette’s syndrome: in search of an “fMRI-friendly” startle paradigm
著者: Neal R. Swerdlow, Blythe Karban, Yvonne Ploum, Richard F. Sharp, Mark A. Geyer, Angela Eastvold - Biological Psychiatry 2001 被引用: 184
- Using an Animal Model of Deficient Sensorimotor Gating to Study the Pathophysiology and New Treatments of Schizophrenia
著者: Neal R. Swerdlow, Mark A. Geyer - Schizophrenia Bulletin 1998 被引用: 617
